Nov. 2020 | IPF Partners announces Final Close of its second Healthcare Growth Debt Fund at c. €187m, well over the initial €140m target
Nov. 2020 | Poxel Presents Phase 1b Clinical Results for PXL065 and New Preclinical Data for PXL770 at AASLD The Liver Meeting® 2020
Oct. 2020 | Poxel Secures EUR 6 Million in Non-Dilutive Financing Guaranteed by the French Government
Oct. 2020 | Poxel Announces Positive Results From Phase 2a NASH Trial With PXL770, an Oral First-in-Class Direct AMPK Activator
Sept. 2020 | Adocia announces Positive Topline Results of Phase 1b Study for M1Pram in People with type 1 Diabetes
